Method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs)

A bone marrow mesenchymal and directional induction technology, applied in the field of tissue engineering cartilage obtained by directional induction of bone marrow mesenchymal stem cells, to achieve stable cartilage phenotype, good general shape, and inhibit hypertrophy in vivo

Active Publication Date: 2015-04-22
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, how to inhibit the hypertrophy and ossification of BMSCs in vivo and maintain the continuous and stable cartilage differentiation is still a bottleneck in clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs)
  • Method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs)
  • Method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] The present invention will be described in detail below in combination with specific embodiments.

[0036] The method for obtaining tissue-engineered cartilage by directional induction of bone marrow mesenchymal stem cells involved in the present invention is realized by the following steps:

[0037] Step 1: Preparation of large aggregates of chondrocytes and extracellular matrix (cell bricks):

[0038] (1) Isolation of chondrocytes, membrane-forming culture:

[0039] The ear cartilage of 1-month-old New Zealand white rabbits was cut into small pieces and treated with 0.2% type II collagenase (Gibco, USA) solution at 37 ○ C for 12 hours, after that, take the single cell suspension and centrifuge at 1000rpm for 5min in a 15ml centrifuge tube;

[0040] Discard the supernatant, wash once with PBS, centrifuge at 1000rpm for 5min, resuspend the cells with film-forming inducing solution, and dilute the cells in a 6.5×10 5 cells / cm 2 The concentration was planted in a 6-we...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for obtaining tissue engineering cartilage through directionally inducing bone-marrow mesenchymal stem cells (BMSCs). At present, a large amount of exogenous growth factors and culture in vitro are needed before culturing the BMSCs and the cartilage cells in vivo to promote the differentiation of the BMSCs towards the cartilage cells. The method comprises the following steps of: mixing the sub-cultured P3-generation BMSCs, the cartilage cells and a large extracellular matrix aggregate (cell brick), resuspending the mixture into a platelet rich plasma to prepare a cell compound of the sub-cultured P3-generation BMSCs, the cell brick and the platelet rich plasma, injecting the compound into the skin on the back of a nude mice when the compound condenses gradually, and culturing to obtain the new tissue engineering cartilage. The completely biological and injectable tissue engineering cartilage is obtained on the basis of coculturing the BMSCs and the cartilage cells. The differentiation of the BMSCs towards the cartilage cells can be kept stably, the hypertrophy of the tissue engineering cartilage in vivo can be inhibited effectively, and the defects in the background art can be overcome.

Description

technical field [0001] The invention relates to a method for constructing tissue engineered cartilage, in particular to a method for obtaining tissue engineered cartilage by directional induction of bone marrow mesenchymal stem cells. Background technique [0002] How to construct an injectable tissue-engineered cartilage with a sustained and stable cartilage phenotype is a major challenge for clinical cartilage defect repair. Bone marrow mesenchymal stem cells (BMSCs) have the potential to differentiate into cartilage. When BMSCs are co-cultured with chondrocytes, the chondrogenic differentiation of BMSCs will be promoted. The current method to promote the differentiation of BMSCs into cartilage requires a large number of exogenous growth factors and in vitro culture operations before in vivo culture. However, how to inhibit the hypertrophy and ossification of BMSCs in vivo and maintain the continuous and stable cartilage differentiation is still a bottleneck in clinical ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/38
Inventor 吴炜巴睿恺赵铱民
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap